← Leaderboards
Russell W Read
University Of Alabama At Birmingham
$979,374
Attributed
$979,374
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $209.4K · FY2005–06$250K$187.5K$125K$62.5K$0
'05
'06
Funding mix
By agency
NIH$979,374 · 1
By mechanism
K08$979,374 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Alabama At Birmingham
Same institution · by research overlap
- Etty N. Benveniste$18,164,533
- Frances E. Lund$38,753,426
- Troy D Randall$33,910,350
- J. Edwin Blalock$21,586,966
- Maria B Grant$24,532,308
Others in their field
Top investigators on “Pathologic Process”
- Paul S. Aisen · Cognition Therapeutics, Inc.$141,221,127
- Reisa A. Sperling · Banner Health$136,913,444
- Constance Ann Benson · University Of California, San Diego$114,806,215
- David A Bennett · Rush University Medical Center$85,949,086
- Stephen A Spector · University Of California, San Diego$77,513,450
- Randall J Bateman · Washington University$70,562,221
Research focus
Pathologic ProcessLaboratory MouseComplement InhibitorsComplement PathwayCytokineGene TargetingGenetically Modified AnimalsImmunopathologyAutoimmune DisorderUveitisChemokine
Grant awards (5)
Complement inhibition in experimental autoimmune uveitis$209,374
K08 · FY2006 · EY · contact PI
Complement inhibition in experimental autoimmune uveitis$202,360
K08 · FY2005 · EY
Complement inhibition in experimental autoimmune uveitis$195,615
K08 · FY2004 · EY
Complement inhibition in experimental autoimmune uveitis$189,130
K08 · FY2003 · EY
Complement inhibition in experimental autoimmune uveitis$182,895
K08 · FY2002 · EY